We are testing a combination of two medications for patients with progressive, treatment-resistant meningiomas. The goal is to see if this approach can improve outcomes for these patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
Meningiomas are tumors that arise from the meninges, the protective membranes covering the brain and spinal cord. They can cause symptoms depending on their size and location, such as headaches, seizures, and changes in vision or hearing.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.